Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.

Literature DB >> 2334161

Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.

G J Cuchural¹, F P Tally, N V Jacobus, T Cleary, S M Finegold, G Hill, P Iannini, J P O'Keefe, C Pierson.

Abstract

A nationwide susceptibility survey of 557 isolates of the Bacteroides fragilis group was continued in 1986. The most active beta-lactam drugs were imipenem and ticarcillin-clavulanic acid, which had 0.2 and 1.7% resistance, respectively. The rank order of activity of beta-lactam drugs was imipenem, ticarcillin-clavulanic acid, cefoxitin, piperacillin, moxalactam, ceftizoxime, cefotetan, cefotaxime, cefoperazone, and ceftazadime.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1990 PMID： 2334161 PMCID： PMC171620 DOI： 10.1128/AAC.34.3.479

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

11 in total

1. Susceptibility of anaerobes to cefoxitin and other cephalosporins.

Authors: F P Tally; N V Jacobus; J G Bartlett; S L Gorbach
Journal: Antimicrob Agents Chemother Date: 1975-02 Impact factor: 5.191

2. Anaerobic infections. 1.

Authors: S L Gorbach; J G Bartlett
Journal: N Engl J Med Date: 1974-05-23 Impact factor: 91.245

3. Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis.

Authors: K Dornbusch; B Olsson-Lijequist; C E Nord
Journal: J Antimicrob Chemother Date: 1980-03 Impact factor: 5.790

4. Improved localization and survival in patients with intraabdominal abscesses.

Authors: S Saini; J M Kellum; M P O'Leary; T F O'Donnell; F P Tally; B Carter; R A Deterling; L E Curtis
Journal: Am J Surg Date: 1983-01 Impact factor: 2.565

Review 5. Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy.

Authors: F P Tally; G J Cuchural; M H Malamy
Journal: Rev Infect Dis Date: 1984 Mar-Apr

6. Susceptibility of the Bacteroides fragilis group in the United States in 1981.

Authors: F P Tally; G J Cuchural; N V Jacobus; S L Gorbach; K E Aldridge; T J Cleary; S M Finegold; G B Hill; P B Iannini; R V McCloskey; J P O'Keefe; C L Pierson
Journal: Antimicrob Agents Chemother Date: 1983-04 Impact factor: 5.191

7. Cefoxitin inactivation by Bacteroides fragilis.

Authors: G J Cuchural; F P Tally; N V Jacobus; P K Marsh; J W Mayhew
Journal: Antimicrob Agents Chemother Date: 1983-12 Impact factor: 5.191

8. Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.

Authors: G J Cuchural; F P Tally; N V Jacobus; S L Gorbach; K Aldridge; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe
Journal: Antimicrob Agents Chemother Date: 1984-08 Impact factor: 5.191

9. Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States.

Authors: F P Tally; G J Cuchural; N V Jacobus; S L Gorbach; K Aldridge; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe
Journal: Antimicrob Agents Chemother Date: 1985-11 Impact factor: 5.191

10. Randomized, prospective, and double-blind trial of new beta-lactams in the treatment of appendicitis.

Authors: W Y Lau; S T Fan; K W Chu; H C Suen; T F Yiu; K K Wong
Journal: Antimicrob Agents Chemother Date: 1985-11 Impact factor: 5.191

12 in total

1. Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Study Group.

Authors: I Phillips; A King; C E Nord; B Hoffstedt
Journal: Eur J Clin Microbiol Infect Dis Date: 1992-04 Impact factor: 3.267

2. In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea.

Authors: K Lee; I H Jang; Y J Kim; Y Chong
Journal: Antimicrob Agents Chemother Date: 1992-01 Impact factor: 5.191

Review 3. Susceptibility testing of anaerobic bacteria: myth, magic, or method?

Authors: H M Wexler
Journal: Clin Microbiol Rev Date: 1991-10 Impact factor: 26.132

Review 4. Current antimicrobial therapy of anaerobic infections.

Authors: C V Sanders; K E Aldridge
Journal: Eur J Clin Microbiol Infect Dis Date: 1992-11 Impact factor: 3.267

5. Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.

Authors: L Dubreuil; J Breuil; A Dublanchet; A Sedallian
Journal: Eur J Clin Microbiol Infect Dis Date: 1992-11 Impact factor: 3.267

6. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996.

Authors: D R Snydman; N V Jacobus; L A McDermott; S Supran; G J Cuchural; S Finegold; L Harrell; D W Hecht; P Iannini; S Jenkins; C Pierson; J Rihs; S L Gorbach
Journal: Antimicrob Agents Chemother Date: 1999-10 Impact factor: 5.191

7. Rationale for selective use of anaerobic blood cultures.

Authors: A J Morris; M L Wilson; S Mirrett; L B Reller
Journal: J Clin Microbiol Date: 1993-08 Impact factor: 5.948

8. Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group.

Authors: E J Goldstein; D M Citron; C E Cherubin
Journal: Antimicrob Agents Chemother Date: 1991-09 Impact factor: 5.191

9. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.

Authors: C Betriu; C Cabronero; M Gomez; J J Picazo
Journal: Eur J Clin Microbiol Infect Dis Date: 1992-04 Impact factor: 3.267

10. Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.

Authors: P Turgeon; V Turgeon; M Gourdeau; J Dubois; F Lamothe
Journal: Antimicrob Agents Chemother Date: 1994-10 Impact factor: 5.191